3:58 PM · 10 July 2023

BREAKING:Novavax on the wave after receiving $350 million for unused COVID shots📈

Novavax's (NVAX.US) share price jumped more than 20% after the biotech company said Canada had agreed to pay $350 million for Covid vaccines that were previously due to be delivered. The settlement, in the case of NVAX, is significant because the company's management expressed doubts about its viability earlier in the year. 

According to the SEC filing, the Canadian government's payment will be made in two equal instalments in 2023. It is worth mentioning that the vaccines for Covid-19 are the company's only commercial product. 

The company's shares are currently testing the limitation formed by the 100-day exponential moving average (purple curve). Source: xStation 5

27 October 2026, 1:51 PM

Market Wrap: Renewed confidence in AI drives stock market recovery (27.10.2026)

26 October 2026, 3:06 PM

US OPEN: Anthropic filing and Iran talks support the market

26 October 2026, 1:38 PM

Anthropic files prospectus ahead of IPO with "ANT" ticker on Nasdaq. The launch date and price remain a mystery

26 October 2026, 11:22 AM

Musk Borrows $40 Billion for AI and Warns Rivals: Neocloud Providers Could Face Serious Trouble

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits